JOSEPH DECOSTA: Open Payments
NPI 1750371605 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 37 payments from 12 companies in 2025. Trend: 2023 $372 · 2024 $548 · 2025 $884
Food & beverage: $884
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $253 |
| Phathom Pharmaceuticals, Inc. | 6 | $175 |
| QOL Medical, LLC | 3 | $94 |
| Madrigal Pharmaceuticals | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Ardelyx, Inc. | 2 | $31 |
| Celltrion USA Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: VOQUEZNA, Sucraid, REZDIFFRA, ENTYVIO, RINVOQ, CREON, DUPIXENT, XIFAXAN.
Industry payments across NC — which companies pay providers there.
